Delivery Order SPE2DB22D3501-SPE2DB25FUX00
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mesalamine DR 400 mg capsules, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $11,025.57 and is a firm fixed-price delivery order, with an ultimate completion date of June 27, 2025. The contract is not designated as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 400 mg capsules, a medication used to treat conditions such as ulcerative colitis. The contract has a ceiling value of $2,967.06 and a performance period ending on June 23, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 180 capsules of 400 mg Mesalamine DR (delayed release) with a ceiling value of $5,439.88. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp. for the supply of Mesalamine ER 0.375 gram capsules. The contract has a ceiling value of $10,911.93 and an ultimate completion date of September 10, 2024. It is a firm-fixed-price contract type. The award is not associated with a set-aside program. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,942,947 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $2,002.92 and a completion date of April 17, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mesalamine DR 400 mg capsules, valued at $10,053.40, with a completion date of November 29, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Mesalamine Delayed-Release 1.2 gram, with a ceiling value of $2,180.50 and a completion date of June 5, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of Mesalamine DR 400 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,652.02 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of September 17, 2024. This contract is not set aside for any specific business category. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.58, is for the delivery of 120 tablets of the pharmaceutical product Mesalamine DR 1.2 GM. The contract has a completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the provision of mesalamine delayed-release capsules to support military treatment programs and facilities. The contract has a ceiling value of $18,821.01 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUX00Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Mesalamine DR 400 mg capsules, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $2,626.74 and a period of performance through March 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/12/25 |